171 related articles for article (PubMed ID: 29688802)
1. Infliximab restores colonic barrier to adherent-invasive E. coli in Crohn's disease via effects on epithelial lipid rafts.
Yakymenko O; Schoultz I; Gullberg E; Ström M; Almer S; Wallon C; Wang A; Keita ÅV; Campbell BJ; McKay DM; Söderholm JD
Scand J Gastroenterol; 2018 Jun; 53(6):677-684. PubMed ID: 29688802
[TBL] [Abstract][Full Text] [Related]
2. High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease.
Darfeuille-Michaud A; Boudeau J; Bulois P; Neut C; Glasser AL; Barnich N; Bringer MA; Swidsinski A; Beaugerie L; Colombel JF
Gastroenterology; 2004 Aug; 127(2):412-21. PubMed ID: 15300573
[TBL] [Abstract][Full Text] [Related]
3. Pathogenic Role of Associated Adherent-Invasive Escherichia coli in Crohn's Disease.
Mazzarella G; Perna A; Marano A; Lucariello A; Rotondi Aufiero V; Sorrentino A; Melina R; Guerra G; Taccone FS; Iaquinto G; De Luca A
J Cell Physiol; 2017 Oct; 232(10):2860-2868. PubMed ID: 27925192
[TBL] [Abstract][Full Text] [Related]
4. Molecular diversity of Escherichia coli in the human gut: new ecological evidence supporting the role of adherent-invasive E. coli (AIEC) in Crohn's disease.
Martinez-Medina M; Aldeguer X; Lopez-Siles M; González-Huix F; López-Oliu C; Dahbi G; Blanco JE; Blanco J; Garcia-Gil LJ; Darfeuille-Michaud A
Inflamm Bowel Dis; 2009 Jun; 15(6):872-82. PubMed ID: 19235912
[TBL] [Abstract][Full Text] [Related]
5. Monocyte-derived macrophages from Crohn's disease patients are impaired in the ability to control intracellular adherent-invasive Escherichia coli and exhibit disordered cytokine secretion profile.
Vazeille E; Buisson A; Bringer MA; Goutte M; Ouchchane L; Hugot JP; de Vallée A; Barnich N; Bommelaer G; Darfeuille-Michaud A
J Crohns Colitis; 2015 May; 9(5):410-20. PubMed ID: 25805890
[TBL] [Abstract][Full Text] [Related]
6. Enhanced E. coli LF82 Translocation through the Follicle-associated Epithelium in Crohn's Disease is Dependent on Long Polar Fimbriae and CEACAM6 expression, and Increases Paracellular Permeability.
Keita ÅV; Alkaissi LY; Holm EB; Heil SDS; Chassaing B; Darfeuille-Michaud A; McKay DM; Söderholm JD
J Crohns Colitis; 2020 Feb; 14(2):216-229. PubMed ID: 31393983
[TBL] [Abstract][Full Text] [Related]
7. Increased uptake of non-pathogenic E. coli via the follicle-associated epithelium in longstanding ileal Crohn's disease.
Keita AV; Salim SY; Jiang T; Yang PC; Franzén L; Söderkvist P; Magnusson KE; Söderholm JD
J Pathol; 2008 Jun; 215(2):135-44. PubMed ID: 18348161
[TBL] [Abstract][Full Text] [Related]
8. Adherent-invasive Escherichia coli (AIEC) in pediatric Crohn's disease patients: phenotypic and genetic pathogenic features.
Conte MP; Longhi C; Marazzato M; Conte AL; Aleandri M; Lepanto MS; Zagaglia C; Nicoletti M; Aloi M; Totino V; Palamara AT; Schippa S
BMC Res Notes; 2014 Oct; 7():748. PubMed ID: 25338542
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D deficiency predisposes to adherent-invasive Escherichia coli-induced barrier dysfunction and experimental colonic injury.
Assa A; Vong L; Pinnell LJ; Rautava J; Avitzur N; Johnson-Henry KC; Sherman PM
Inflamm Bowel Dis; 2015 Feb; 21(2):297-306. PubMed ID: 25590952
[TBL] [Abstract][Full Text] [Related]
10. Adherent-Invasive E. coli enhances colonic hypersensitivity and P2X receptors expression during post-infectious period.
Lashermes A; Boudieu L; Barbier J; Sion B; Gelot A; Barnich N; Ardid D; Carvalho FA
Gut Microbes; 2018 Jan; 9(1):26-37. PubMed ID: 28806140
[TBL] [Abstract][Full Text] [Related]
11. Adherent-invasive Escherichia coli induce claudin-2 expression and barrier defect in CEABAC10 mice and Crohn's disease patients.
Denizot J; Sivignon A; Barreau F; Darcha C; Chan HF; Stanners CP; Hofman P; Darfeuille-Michaud A; Barnich N
Inflamm Bowel Dis; 2012 Feb; 18(2):294-304. PubMed ID: 21688348
[TBL] [Abstract][Full Text] [Related]
12. Let-7b ameliorates Crohn's disease-associated adherent-invasive E coli induced intestinal inflammation via modulating Toll-Like Receptor 4 expression in intestinal epithelial cells.
Guo Z; Cai X; Guo X; Xu Y; Gong J; Li Y; Zhu W
Biochem Pharmacol; 2018 Oct; 156():196-203. PubMed ID: 30142321
[TBL] [Abstract][Full Text] [Related]
13. Characterization of adherent-invasive Escherichia coli isolated from pediatric patients with inflammatory bowel disease.
Negroni A; Costanzo M; Vitali R; Superti F; Bertuccini L; Tinari A; Minelli F; Di Nardo G; Nuti F; Pierdomenico M; Cucchiara S; Stronati L
Inflamm Bowel Dis; 2012 May; 18(5):913-24. PubMed ID: 21994005
[TBL] [Abstract][Full Text] [Related]
14. Rifaximin decreases virulence of Crohn's disease-associated Escherichia coli and epithelial inflammatory responses.
Dogan B; Fu J; Zhang S; Scherl EJ; Simpson KW
J Antibiot (Tokyo); 2018 May; 71(5):485-494. PubMed ID: 29410518
[TBL] [Abstract][Full Text] [Related]
15. Adherent-invasive Escherichia coli: a putative new E. coli pathotype associated with Crohn's disease.
Darfeuille-Michaud A
Int J Med Microbiol; 2002 Sep; 292(3-4):185-93. PubMed ID: 12398209
[TBL] [Abstract][Full Text] [Related]
16. Saccharomyces cerevisiae CNCM I-3856 prevents colitis induced by AIEC bacteria in the transgenic mouse model mimicking Crohn's disease.
Sivignon A; de Vallée A; Barnich N; Denizot J; Darcha C; Pignède G; Vandekerckove P; Darfeuille-Michaud A
Inflamm Bowel Dis; 2015 Feb; 21(2):276-86. PubMed ID: 25569734
[TBL] [Abstract][Full Text] [Related]
17. Quantification and characterization of mucosa-associated and intracellular Escherichia coli in inflammatory bowel disease.
Elliott TR; Hudspith BN; Wu G; Cooley M; Parkes G; Quiñones B; Randall L; Mandrell RE; Fagerquist CK; Brostoff J; Rayment NB; Boussioutas A; Petrovska L; Sanderson JD
Inflamm Bowel Dis; 2013 Oct; 19(11):2326-38. PubMed ID: 23989750
[TBL] [Abstract][Full Text] [Related]
18. Characterization of mucosa-associated Escherichia coli strains isolated from Crohn's disease patients in Brazil.
Costa RFA; Ferrari MLA; Bringer MA; Darfeuille-Michaud A; Martins FS; Barnich N
BMC Microbiol; 2020 Jun; 20(1):178. PubMed ID: 32576138
[TBL] [Abstract][Full Text] [Related]
19. Inflammation-associated adherent-invasive Escherichia coli are enriched in pathways for use of propanediol and iron and M-cell translocation.
Dogan B; Suzuki H; Herlekar D; Sartor RB; Campbell BJ; Roberts CL; Stewart K; Scherl EJ; Araz Y; Bitar PP; Lefébure T; Chandler B; Schukken YH; Stanhope MJ; Simpson KW
Inflamm Bowel Dis; 2014 Nov; 20(11):1919-32. PubMed ID: 25230163
[TBL] [Abstract][Full Text] [Related]
20. Hyperresponsiveness of the mucosal barrier in Crohn's disease is not tumor necrosis factor-dependent.
Suenaert P; Bulteel V; Vermeire S; Noman M; Van Assche G; Rutgeerts P
Inflamm Bowel Dis; 2005 Jul; 11(7):667-73. PubMed ID: 15973122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
